Skip to main content
Back to Lightspeed Venture Partners

Lightspeed Venture Partners's Pharmaceutical Portfolio

Browse 6 Pharmaceutical companies funded by Lightspeed Venture Partners. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
6
Total Funding in Pharmaceutical
$825.4M

Pharmaceutical Portfolio Companies (6)

Export
Artificial Intelligence (AI)BiotechnologyLife SciencePharmaceuticalTherapeutics

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

Boulder, United States
September 2026
$311.0M
Series E

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Boston, United States
September 2023
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Schlieren, Switzerland
September 2024
$11.0M
Series C

Founder Contacts

41,000+ verified contacts

Health CareMedicalPharmaceutical

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Menlo Park, United States
January 2026
$250.0M
Series F

Founder Contacts

41,000+ verified contacts

DeliveryHealth CarePharmaceutical

MAYD Group operates as a startup that delivers medicines in minutes.

Berlin, Germany
January 2022
$33.4M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

41,000+ verified contacts

Explore Lightspeed Venture Partners's Full Portfolio

View all companies funded by Lightspeed Venture Partners across every industry and funding stage.

View Full Lightspeed Venture Partners Portfolio